The Histopathology Core provides a wide spectrum of histology and microscopy services to meet the growing needs of diabetes researchers at Columbia University and affiliated institutions. Over the previous funding cycle, due to ovenwhelming demand for these essential services, the histopathology laboratory (formerly part of the Phenotyping core) and microscopy services (formeriy part of the Genomics core) have been consolidated into a new Histopathology Core. The services of this new core include the high quality basic histological and microscopy services offered in the previous funding cycle, but have been expanded to accommodate the changing and growing needs of DRC users and to incorporate newly developed reagents and technologies. Furthermore, Dr. Sussel, a leader in islet biology and pancreas development was recruited to Columbia University and the Berrie Diabetes Center in 2008 and was enlisted to develop and direct this new core. Since its establishment in 2008, the Histopathology Core has assisted 32 DRC investigators supported by 69 grants and 6 non-DRC investigators on projects that have resulted in 61 papers (29 as primary Core) and/or provided data that helped investigators obtain 14 new grants. It has processed 30,000 samples, cut -300,000 sections and performed 36,000 immunohistochemical stains, nearly 18,000 of which by immunofluorescence. The Core plans to continue to provide advanced histophenotyping capabilities to the thriving Columbia University diabetes research community. To this end, the Core will seamlessly integrated its operation with that of the other DRC Core facilities, to maintain an investigator-oriented approach to service and development, implement and sustain effective business practices, and assist the DRC in its overall mission.
Tissue phenotyping is an essential component of analytical tools to understand, diagnose, and treat diabetes. The purpose of this facility is to ease access to complex, time-consuming, and technically intensive procedures to assist DRC investigators, accelerate discovery, streamline practices, and reduce costs and animal use.
|Kode, A; Mosialou, I; Manavalan, S J et al. (2016) FoxO1-dependent induction of acute myeloid leukemia by osteoblasts in mice. Leukemia 30:1-13|
|Kim-Muller, Ja Young; Kim, Young Jung R; Fan, Jason et al. (2016) FoxO1 Deacetylation Decreases Fatty Acid Oxidation in Î²-Cells and Sustains Insulin Secretion in Diabetes. J Biol Chem 291:10162-72|
|Kuo, Taiyi; Kim-Muller, Ja Young; McGraw, Timothy E et al. (2016) Altered Plasma Profile of Antioxidant Proteins as an Early Correlate of Pancreatic Î² Cell Dysfunction. J Biol Chem 291:9648-56|
|Lerea, Jaclyn S; Ring, Laurence E; Hassouna, Rim et al. (2016) Reducing Adiposity in a Critical Developmental Window Has Lasting Benefits in Mice. Endocrinology 157:666-78|
|Xuan, Shouhong; Sussel, Lori (2016) GATA4 and GATA6 regulate pancreatic endoderm identity through inhibition of hedgehog signaling. Development 143:780-6|
|Grijalva, Ambar; Xu, Xiaoyuan; Ferrante Jr, Anthony W (2016) Autophagy Is Dispensable for Macrophage-Mediated Lipid Homeostasis in Adipose Tissue. Diabetes 65:967-80|
|Juan De Solis, Alain; Baquero, Arian F; Bennett, Camdin M et al. (2016) Postnatal undernutrition delays a key step in the maturation of hypothalamic feeding circuits. Mol Metab 5:198-209|
|Madra, M; Zeltser, L M (2016) BDNF-Val66Met variant and adolescent stress interact to promote susceptibility to anorexic behavior in mice. Transl Psychiatry 6:e776|
|Kim-Muller, Ja Young; Fan, Jason; Kim, Young Jung R et al. (2016) Aldehyde dehydrogenase 1a3 defines a subset of failing pancreatic Î² cells in diabetic mice. Nat Commun 7:12631|
|Li, Dylan; Zhang, Feng; Zhang, Xuan et al. (2016) Distinct functions of PPARÎ³ isoforms in regulating adipocyte plasticity. Biochem Biophys Res Commun 481:132-138|
Showing the most recent 10 out of 192 publications